Leidos Holdings, Inc. - LDOS STOCK NEWS

On February 7, 2023, Leidos (NYSE:LDOS) announced the deployment of its ClearScan™ computed tomography (CT) scanner at Frankfurt Airport (FRA), marking a significant advancement in airport security. This initiative, led by Fraport, aims to enhance passenger processing amid rising travel demands and staff shortages. The ClearScan technology utilizes advanced explosives detection algorithms, allowing passengers to keep approved electronics and liquids in their bags, thereby reducing wait times. Leidos continues to support global airports in modernizing security operations with this innovative technology, which has already seen successful implementations in other major cities.

Leidos Partnership for Defense Health successfully deployed the MHS GENESIS electronic health record system to 11 Military Treatment Facilities, benefiting an estimated 12,000 clinicians across several states including Connecticut and Virginia.

This deployment is part of a larger initiative, with the system now operational in over 2,200 locations and serving approximately 6.1 million DOD beneficiaries. The program remains on track to complete all continental U.S. deployments by the end of the calendar year, enhancing clinical outcomes and leveraging best practices.

Leidos (NYSE: LDOS), a leader in science and technology, will participate in the Cowen 44th Annual Aerospace/Defense & Industrials Conference on February 15, 2023, from 2:05 p.m. to 2:45 p.m. ET. CEO Roger Krone will hold a fireside chat during this event, which will be held in Arlington, VA. A live audio webcast of the event will be available on the Leidos Investor Relations website, with a replay accessible for 30 days post-event. Leidos reported approximately $13.7 billion in annual revenues for the fiscal year ended December 31, 2021.

Leidos (NYSE: LDOS) announced the launch of version 2.0 of its Zero Trust Readiness Level (ZTRL™) tool suite on February 1, 2023. This suite is aimed at accelerating Zero Trust adoption in government agencies, streamlining what typically takes 6-9 months into less than 60 days. ZTRL 2.0 introduces features such as continuous reporting and customizable dashboards to aid compliance with the Cybersecurity and Infrastructure Security Agency (CISA) Zero Trust Maturity Model. Leidos leverages experience from managing large federal networks, citing its Zero Trust Proving Ground and partnerships with major cybersecurity companies.

Leidos (NYSE: LDOS) has appointed Srini N. Iyer as the new Chief Technology Officer for its Health Group, effective January 25, 2023. Iyer brings over 30 years of experience in driving innovation and will focus on expanding the Health Group's portfolio. Previously, he held the position of Senior Vice President and Corporate Chief Technology Officer at ManTech International and has significant experience with Northrop Grumman Technical Services. Leidos, headquartered in Reston, Virginia, reported annual revenues of approximately $13.7 billion for the fiscal year ending December 31, 2021.

Leidos (NYSE: LDOS), a technology leader, has secured two new task orders worth a combined $1.5 billion under the IT Support Services Contract II from the Social Security Administration (SSA). These contracts, which include a base period and multiple option years, will enhance support for the SSA's systems and infrastructure, specifically in areas like software systems and enterprise IT. The company’s ongoing collaboration with the SSA spans nearly three decades, indicating a strong partnership in supporting its mission to provide financial protection to Americans.

Leidos (NYSE:LDOS) announced the appointment of retired Colonel Bobby Saxon as Vice President and Strategic Account Executive for the U.S. Department of Health & Human Services (HHS) on January 18, 2023. Saxon, a seasoned federal health leader with extensive military and IT experience, is tasked with strengthening relationships with HHS and advancing strategic initiatives to drive company growth. Prior to joining Leidos, he held key positions at the Centers for Medicare & Medicaid Services, including Deputy Director and Chief Information Officer. Leidos, headquartered in Reston, VA, reported annual revenues of approximately $13.7 billion for the fiscal year ending December 31, 2021.

Leidos (NYSE: LDOS) has announced a conference call scheduled for February 14, 2023, at 8 a.m. ET to discuss its fourth quarter and full year 2022 financial results. The earnings press release will be available prior to the call. Investors can access a live audio broadcast and replay through Leidos' Investor Relations website. Leidos, a FORTUNE 500® company, reported annual revenues of approximately $13.7 billion for the fiscal year ending December 31, 2021.